Whitepapers

Personalised medicine aims to deliver the right medicine to the right patient at the right time.1 It targets treatments to patients that are most likely to benefit from them, in…
Read More...

The Trump administration has consistently and persistently threatened the health care and guaranteed safeguards that millions of American families rely on over the past two years.…
Read More...

The National Cancer Intelligence Network (NCIN) is a UK-wide partnership operated by Public Health England. The NCIN coordinates and develops analysis and intelligence to drive…
Read More...

The new health care demands that providers deliver quality care while controlling costs. That’s why the number of ACOs has risen in recent years. Use these six steps to achieve…
Read More...

In light of recent advances in medical technology and the increasing demand for cancer treatment on Long Island, Memorial Sloan Kettering Cancer Center is undergoing a major…
Read More...

For the sake of clarity, the definition of the term ‘adverse reaction’ should be amended to ensure that it covers noxious and unintended effects resulting not only from the…
Read More...

With time and resources at a premium, healthcare organizations are increasingly selective about allocation of human and financial capital. There are, however, a select group of…
Read More...

Before placing a medical device on the European market, manufacturers need to produce technical documentation providing evidence of conformity with the relevant legislation.…
Read More...

The drugs represented have been reviewed by a National Pharmacy and Therapeutics (P&T) Committee and are approved for inclusion. The document is reflective of current medical…
Read More...

The United States has seen a marked increase in the use of electronic information and a resulting increase in the level of exposure to cyber attacks, which target an…
Read More...